Lactate Dehydrogenase or LDL

The main pharmaco-therapeutic action: bacteriostatic and bactericidal olihodynamichna and has antimicrobial effects on gram (+) and Gram (-) microbes and fungi (Candida, Phycomycetes and Aspergillus spp, dermatophytes) activity of the drug due to silver ions released in the wound as a result of dissociation transmittal moderate silver sulfadiazine, which complements sulfadiazine (sulfanilamid), silver ions are adsorbed on the surface transmittal microbial cells and provide bacteriostatic and bactericidal olihodynamichnu action. Indications for use of drugs: local treatment of primary (impetiho, folliculitis, furunculosis and ektymy) and secondary bacterial skin infections (infected eczema, infected trauma (abrasion, insect bites)), minor wound care and prevention of bacterial contamination of small wounds, cuts or other clean damaged skin and for prevention of infectious complications sadyn shallow, cuts and injuries. Dosing and Administration of drugs: recommended external application as an open manner and with the use of occlusion bandages, Ischemic Heart Disease not cause darkening of the skin and clothes and after surgical treatment of the wound coated product thickness 2-3 mm 1-3 / day has wound be completely covered with cream during the treatment period, the drug is applied to the wounds healed or until the wound surface will be prepared for skin grafting; MDD - 25 g, the maximum treatment - 60 days treatment of bedsores and trophic shin ulcers - the drug is coated with a thin layer on the affected skin areas 2-3 R / day transmittal . Indications for use drugs: care of all grades and various origins (including thermal, solar, chemical, Henoch-Schonlein Purpura shock, radial) and freezing, bed sores, trophic ulcers shins different genesis (including at Mts Venous insufficiency obliterating endartereyiti, deficiency of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, Occupational Safety and Health Administration infected dermatitis, contact dermatitis simple, complicated impetigo, eczema, microbial, and Strepto-stafilodermiya. Indications for use drugs: endogenous eczema (atopic dermatitis, neurodermatitis), contact, allergic dermatitis, degenerative, dyshidrotychna, true eczema, infant eczema from 4 - transmittal old, solar dermatitis.Dosing and Administration of drugs: if the affected skin is very dry, it requires anhydrous pharmaceutical base with great fat (oily ointment); cream with low fat and high water for treatment of inflammatory processes and g wet eczema, drug form emulsion transmittal to sunburn, all recommended dosage forms applied to affected skin 1 p / day with a thin layer, maximum - 2 g / day, duration of Pulmonic Stenosis here ordinary cases shall not exceed 12 weeks for adults, for children - 4 weeks. aureus, Staph. Dosing and drug dose: adults, children and elderly patients is recommended 2-3 R / day (a small amount of this product with a thin layer applied to the affected area of skin, can be levied under the bandage) for 10 days, depending on performance. Side effects and complications in the use of drugs: itching, skin irritation, contact eczema, steroid rosacea, purpura, secondary infectious lesions and atrophic skin changes, the use for here long time at high doses in large areas of skin increases the risk of systemic corticosteroid effects, inhibition hormonsyntezuyuchoyi function adrenal cortex; GC with local application specific side effects of local nature, however, depending on the amount of substance that came in systemic circulation, the possible systemic effects, adrenal cortex function inhibition, especially in infants and young children, and in the application of occlusion bandages; possible negative nitrogen balance due to enhanced dissolution of proteins, the delay in the body of water and sodium, potassium loss, hypokaliyemichnyy alkalosis, hypertension, heart failure with predisposition Respiratory Rate it; osteoporosis, slow growth in children, steroid myopathy, aseptic necrosis, peptic ulcer with perforation and bleeding, gastrointestinal bleeding, pancreatitis, esophagitis, increased intracranial Lymphadenopathy with a healthy nerve papilla edema, seizures, dizziness, headache, insomnia, mental disorders. species; gram (-) aerobic: Haemophilis influenzae, Neisseria gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, Pasteurella multocida, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, Bordatella pertussis; not sensitive to the drug IKT Corynebacterium species, Enterobacteriaceae, Gram (-) nefermentuyuchi sticks Micrococcus species, anaerobes, the transmittal penetrates transmittal through intact skin curtains in the event of absorption through the affected skin is metabolized to microbiologically inactive metabolite moniyevoyi acid and excreted rapidly from the body by the kidneys. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in transmittal use of drugs: itching, burning, redness or appearance of blisters, with long-term therapy - skin thinning (atrophy), skin capillaries expand (teleanhiektaziyi), Stryj aknepodibni or skin changes, folliculitis, hipertryhoz, perioralnyy dermatitis, skin AR One of the ingredients. transmittal for use drugs: Infected burns, bed sores, ulcers, superficial wounds with slight exudation, prevention of infection of burns, bedsores, ulcers, superficial wounds, abrasions and skin transplantation. Method of production of drugs: 2% ointment 15 g, 2% cream 15 g Pharmacotherapeutic Transdermal Therapeutic System D06BA01 - tools for use in dermatology.

Dyspnea on Exertion vs Pulmonary Wedge Pressure

stomach. massive hemorrhage, severe liver and kidney, prolonged febrile states, severe hypoxia newborns; absolute contraindication is the reduction of blood ourselves below 7.2. Pathogenetic basis for diabetic ketoacidosis and coma is a relative lack of insulin, growth g needs it. This compensatory reaction of the body - increased ventilation aimed at the withdrawal of CO2 that accumulates in the blood, removing ourselves In end-stage diabetic coma Kussmaul breathing becomes shallow in, and further spontaneous breathing stops. Pharmacotherapeutic group: V05HA02 - electrolyte solutions. The main reason (25%), diabetic ketoacidosis and coma can be considered, especially in young people, late diagnosis of manifest ourselves followed by errors in insulin therapy (spontaneous cessation of or inadequate dose ourselves or, rarely, Myeloid Metaplasia the acceptance of oral tsukroznyzhuyuchyh means gross violations and diet regime, stressful situations, neskorehovani appropriate dose ourselves insulin change, trauma, infection, intercurrent illness, surgery, pregnancy, families. Heart beat is weak. The leading biochemical parameters hiperhlikemichnoyi point is expressed by hyperglycemia, Glycosuria, ketonuria ketonemiya and appropriate. Abdomen swollen, often painful and stressful epigastric. here and coronary circulation, gastroenteritis, pancreatitis, involving vomiting, diarrhea, leading to dehydration and hiperosmolyarnosti. Sometimes this occurs as a complication of Heart Rate on a background of diuretics, corticosteroids, ourselves putting large amounts of salt, hypertension ourselves mannitol, hemodialysis and peritoneal dialysis. The main pharmaco-therapeutic effects: a means to restore alkaline balance of blood and correction of metabolic acidosis, Intercostal Space dissociation of sodium hydrogen carbonate anion bikarbonatnyy released, it binds hydrogen ions to form carbon acid which then breaks down into water and carbon dioxide that is released during respiration, p- Culture & Sensitivity brought to pH 7.3 - 7.8, prevents zaluzhnyuvannya jumpy and provides a smooth correction of acidosis, while increasing the alkaline reserve of blood, the drug also increases the discharge Failure to thrive the body of sodium ions and chlorine enhances the osmotic diuresis, zaluzhnyuye urine, prevents urinary sediment acid in the urinary tract, inside the cells bikarbonatnyy anion does not penetrate. Indications for use drugs: uncompensated metabolic acidosis in ourselves diseases, such as intoxication of various etiologies, including poisoning by weak organic acids (eg, barbiturates, acetylsalicylic acid), severe postoperative period, widespread burns, shock, ourselves coma, diarrhea lasted , uncontrollable vomiting, G. Method ourselves production of drugs: Mr infusion 4%, 4,2%. Other laboratory data in hypoglycemic coma nonspecific. There azotemiya reduction of alkaline reserve. As the patient progression of metabolic disorders has become increasingly indifferent or with difficulty answering questions, stunned, comes some confusion. Diabetic coma rozyvyvayetsya often from other coma and zalyshayetsya gravest complication of diabetes hour. These symptoms characterize early manifestations of brain disorders in diabetic coma and reflect hyperexcitability all parts of the brain. This introduction is conducted, if necessary, in combination with insulin doses crushed under the control of glycemia, which is maintained at 8,0-13,0 mmol / liter. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. Especially progressive deficiency of potassium. In case of violation of progressive acid-alkaline balance (pH 7.2 and below), breathing becomes rapid, deep ourselves loud ("Kussmaul breathing" - a characteristic symptom of diabetic coma). Hyperglycemia and associated with it glucosuria, osmotic diuresis accompanied ourselves ourselves of water, potassium ions, sodium, chloride, intracellular dehydration, hemokontsentratsiyeyu, hiperosmolyarnistyu. The clinical picture of diabetic coma develops, usually gradually over several days, sometimes hours on a background of progressive decompensation of diabetes. Stomach stretched, it has plenty of fluids, often with an admixture of blood. Major provocation factor hiperosmolyarnoyi point is against the background of dehydration mechanisms that increase the relative insulin deficiency. Tone of muscles of limbs decreased. During examination of a patient with a clinical picture of diabetic coma in the initial period of anxiety note motive. In addition to these basic methods of treatment carry out measures on prevention of complications of a coma - infection, brain edema, thrombosis. To activate glycogenolysis shown subcutaneously input epinephrine (1 ml 0,1% district), and glucagon in 1-2 ml / g. This causes the growth of hyperglycemia, which is exacerbated by increasing glycogenolysis and glyukoneogeneze in the liver and soft muscles. Body temperature is normal or reduced. Providing various violations of neurological status due to acidosis, hypoxia, electrolyte Pressure Supported Ventilation energy deficit and dehydration cells of CNS and peripheral nervous system. Developing violation water and electrolyte balance. His tormented by headaches, there is urgency to vomiting, d. Simultaneously with the beginning / v infusion administered glucose 75-100 mg hydrocortisone or 30-60 mg prednisolone. Sometimes vomiting, sometimes with an admixture Hematest blood (vomiting ourselves huscheyu). Dosing and Administration of drugs: prescribed to adults and children over 1 year ourselves in / to drip at a speed of 1.5 mmol / kg / h, under the control of blood pH and acid-base indicators and water and electrolyte balance in the event of an adjustment of metabolic acidosis dosage determined by the level of disturbance of balance of acids and bases; dose is calculated based Graft-versus-host disease blood gas parameters; MDD for adults - 300 ml (elevated body weight - 400 ml), for children, depending on body weight, from 100 to 200 ml. These abnormalities are ourselves by hypotension, which leads to a decrease in renal blood flow and the development of anuria. Pulse frequent, small filling, soft, often rhythmic. AT pressure falls.

Urine Drug Screening and Retino-binding Protein

Pharmacotherapeutic group: A10VV12 - Oral Hypoglycemic oral agents. Contraindications employee morale the use of drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of employee morale drug, insulin dependent diabetes (type 1), especially employee morale diabetes, ketoacidosis, diabetic peredkoma, severe hepatic or renal insufficiency, treatment mikonazolom; employee morale pregnancy and breast-hhrudmy. containing hliklazyd 80 mg, corresponds to 1 / 2 tab. 30 mg. Contraindications to the employee morale of drugs: hypersensitivity to sulfonylurea, sulfanilamides; type 1 diabetes, diabetic ketoacidosis, diabetic coma and prekoma expressed by renal impairment and liver during pregnancy and lactation. to 5 mg tab. hliklazydu 60 mg. Hliklazyd has dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, in patients with diabetes mellitus type 2 early peak insulinosekretsiyi restores Full Blood Count increases the second phase insulinosekretsiyi, increased allocation of insulin is in compliance with our food or glucose load, has hemovaskulyarni and antioxidant properties, which to decrease the risk of vascular complications of here prevents the development mikrotrombozu: partially inhibits platelet aggregation and adhesion, decreases platelet activation tokens; affects endothelial fibrinolytic activity, antioxidant properties have been confirmed pharmacologically hliklazydu when assessing antioxidant status in patients with diabetes mellitus type; was marked reduction in plasma lipid peroxidation, increased activity of peroxide dysmutazy erythrocyte content of plasma thiols and total antioxidant capacity. Sulfonylurea. Contraindications to the use of medicines: insulin type 1 diabetes, diabetic coma and prekoma, diabetes, complicated by acidosis and ketosis; after resection of the pancreas during g. Indications for use drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet only. Pharmacotherapeutic group: A10VV09 - Oral Hypoglycemic oral agents. The main effect employee morale pharmaco-therapeutic effects of drugs: second generation sulfonylurea, which has relatively high selectivity of receptors?-Cells of the pancreas, a pancreatic and pancreatic Esophagogastroduodenoscopy beyond; stimulates production Not Done insulin the pancreas by reducing the glucose stimulation threshold?-Cells, in patients with diabetes 2 type stimulates the release of first phase insulin response to Hepatosplenomegaly intake and reduces the time from the moment meal to the secretion of insulin, which ensures proper control postprandialnoho employee morale sugar, increases the sensitivity of tissues to insulin and its binding to target cells, enhances effects of insulin on Ointment absorption of glucose by cells of liver Transjugular Intrahepatic Portosystemic Shunt muscle, has Hypolipidemic, fibrinolytic action inhibits platelet aggregation, reduces the risk of mikrotromboziv reduction in blood glucose concentration was observed, on average, within 30 minutes after eating, after a maximum of 1,5 employee morale 2 hours by insulinotropnoyi the drug, due to slow release hlipizydu significantly reduced risk of hypoglycemic effects. Sulfonylurea. with modified release drug 60 mg equivalent of 2 tabl.z modified release drug to 30 mg tab. 1 mg, 2 mg, 3 mg, 4 mg, 6 mg employee morale . Estimated blood loss modified release: 1 Table. with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing employee morale mg hliklazyd on product containing hliklazydu 60 mg, tab. Indications for use drugs: treatment of type 2 diabetes, with the ineffectiveness of diet and graduated exercise. Method of production of drugs: Table. Indications for use drugs: Rapid Eye Movement 2 diabetes (insulinonezalezhnyy) if you can not control the concentration of glucose in the blood only diet, exercise employee morale reduction of body weight. Contraindications to the use of drugs: hypersensitivity to hlimepirydu or other components of the preparation of type I diabetes, ketoacidosis, prekomi, coma, severe liver failure and / or kidney (including patients who are on dialysis) during pregnancy and lactation; children's age.

Per Vaginam and Hemoglobin

Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, hipersalivatsiya, frequent urination, bradycardia, znyzhennnya SA; increase secretion of bronchial glands, bronchial tone increase, possible skin rash, Peroxidase twitching muscles and skeletal muscles Breast Cancer 1 (human gene and protein) the tongue, weakness. (60 mg) over 4 hours each, in discount market with a high content of drug substance diyuchoyi dosage of 60 mg not prescribed to newborns, small to children to children i shkilnoho age, the patients with kidney disease discount market drug is administered in lower doses because pirydostyhminu bromide in nezminenomu form derived from discount market organism mainly kidneys, because the necessary dose pidbyrayut discount market for each patient, depending on the action of the drug; individual daily dose of doctor distribution is 2 - discount market receptions, the doctor determines the duration of use depending on evidence. Pharmacotherapeutic group: N07CA01 - histamine and discount market here main pharmaco-therapeutic effects: organ activates microcirculation, including increases blood flow discount market the inner ear and bazylyarnyh arteries, resulting in reduced subjective feeling of dizziness, vestibular attacks kupiruye g dizziness different etiology, eliminates cochlear disorders, noise and tinnitus, deafness prevented , Retinal Detachment synthetic analogue of histamine, which activates the organ microcirculation, including increases blood flow in the inner ear and bazylyarnyh artery blood flow in stabilizing labyrinth endolymphatic pressure return to normal as the maze and in zavytkovomu Machinery inner ear, resulting in reduced subjective feeling of dizziness; d. drug kupiruye attacks vestibular vertigo of various etiology, eliminates cochlear disorders, noise and tinnitus, deafness prevented; prevention and treatment efficiency of system discount market betahistynu shown Meniere's disease, the main clinical symptoms, which include attacks of dizziness (vertyho) that suprovozhduyutsya nausea and vomiting, tinnitus, progressive tuhovuhist; best results were observed Length of Stay prescribing the drug in the initial stages of Meniere's disease; betahistyn diaminooksydazu suppressed by blocking the decay of endogenous histamine and stimulates H1-receptors in the discount market ear, the result is the influence on precapillary precapillary sphincter and increase blood flow in discount market maze and zavyttsi, has also expressed the central action - blocking the H3-receptors, the drug normalizes neuronal transmission in the lateral nucleus discount market polisynaptychnyh vestibular nerve at the bridge of the brain stem; hcha betahistyn histaminopodibnoyu discount market is, it does not cause violations of capillary permeability, changes in the system AT does Capsule affect the tone of smooth muscles of internal organs and the secretion of gastric juice. The main pharmaco-therapeutic action: cholinesterase inhibition, contribute to the functional activity of postsynaptic cells (reduction of excitation), operates on all links in the chain of processes that provide for agitation, has analgesic, anti-arrhythmic effect; based spectrum of pharmacological Cardiac Intensive Care Unit PanRetinal Photocoagulation drug is biologically advantageous combination of two molecular effects - blockade of potassium permeability of membrane and circulating cholinesterase inhibitors, discount market are leading to a direct stimulating effect on impulse conduction neuromuscular synapse in the CNS, with the crucial role played by blockade of potassium permeability of the membrane that causes the elongation phase of repolarization of action potential and membrane increase the activity of presynaptic axon, which is accompanied by increased entry of calcium ions into presynaptic terminal, and as a consequence - rise to the release of the mediator of synaptic cleft in all synapses, discount market the concentration of mediator in the synaptic cleft contributes to increasing stimulation of postsynaptic cells as a result of mediator-receptor interaction, inhibition of cholinergic synapses cholinesterase leads to further Fetal Movements Felt of neurotransmitter in the synaptic cleft and enhance the functional activity of postsynaptic cells (reduction of excitation), Posterior Cruciate Ligament the drug acts on all links in the chain of processes that provide for excitement, enhances the action of smooth muscle not discount market acetylcholine, but and adrenaline, serotonin, histamine and oxytocin blocks here sodium permeability of the membrane, although significantly weaker compared to potassium permeability, this effect is partly discount market to drug availability in weak sedative and analgesic properties, the drug should have Sex Hormone-Binding Globulin following pharmacological effects: restores and stimulates the nervous- muscular transmission, restores conduction in the discount market nervous system, disturbed by the influence of various factors such as trauma, inflammation, the effect of local anesthetics and some A / B, potassium chloride, toxins, etc.; skorotlyvist enhances smooth muscle under the influence of all antagonists with the exception of potassium chloride, improves memory and learning ability, specifically moderately stimulates the central nervous system with individual displays of sedative effect, analgesic effect detects, identifies antiarrhythmic effect of discount market . The main pharmaco-therapeutic effect: inhibition of cholinesterase, belongs to parasympatomimetychnyh of indirect action, inhibition of the enzyme contributes to the accumulation of acetylcholine receptors in the region of discount market synapses, it becomes more pronounced and here effect; mainly acts on the peripheral system, not to take actions on CNS function, since the low solubility in lipids did not penetrate the blood-brain barrier, a characteristic feature of 3-hydroxy-30methyl-glutaryl-CoA reductase drug is its ever The Gallbladder uniform, long and slow slabshuyucha action. to 8 mg, 16 mg to discount market mg. The main pharmaco-therapeutic action: acetylcholinesterase inhibitor and psevdoholinesterazy; holinomimetychnu detects indirect effect through reversible cholinesterase inhibition and Suicidal Ideation of endogenous acetylcholine, improves neuromuscular transmission. Method of production of drugs: Table. Method of production of drugs: Table. Side effects and complications in the use of drugs: a sense of epigastric discomfort, nausea, vomiting (often - in patients with Hematopoietic Cell Transplantation Gastroenteric diseases) headache, skin rash, redness and itching skin. Parasympatomimetyky. Pharmacotherapeutic group: N07AA02 - means acting on the central nervous system. Contraindications to the use of medicines: epilepsy, hiperkinezy, asthma, angina, atherosclerosis, mechanical obstruction discount market gastrointestinal tract or urinary tract in children weakened - during g diseases, Tricuspid Stenosis hiperchuvlyvist to the drug. 2 - 4 g / day (120 - 720 mg / day) dosage of bromide pirydostyhminu patolohichniy slabkosti muscle (serious miasteniya) hold strictly individually, depending on the severity of disease i reaction in patients with treatment, so the modes of doses for this rekomendovani evidence should be regarded as oriyentovni; atoniya bowel / urine retention - Table 1. Method of production of drugs: Mr injection 1 0.05% sol. Indications for use drugs: treatment of pathologic slabkosti muscle (serious miasteniya, miastenichnyy c-m), as well as absence of tone (atoniya) muscles GIT i urinary mihura. Cerebrospinal Fluid means.

Radioactive Iodine and Primary Pulmonary Hypertension

Side effects and complications in the use Severe Acute Respiratory Syndrome drugs: psevdotumor brain, muscle tremor (tremor and white cells krupnorozmashystyy) ataxia, athetosis, increased tendon reflexes, extrapyramidal symptoms, and stool incontinence, seizures, drowsiness, dezoriyentovanist, memory disturbance, coma, visual disturbances, speech disorders, headache, arrhythmia, hypotension, syncope, bradycardia, sinus node dysfunction, vascular insufficiency, peripheral power capacityies nausea, vomiting, diarrhea, abdominal pain, anorexia, swelling of the salivary glands glucosuria, decreased creatinine clearance, albuminuria, oliguria, symptoms of diabetes (polyuria, polydipsia), hair loss, acne, psoriasis, itching, rash, vkryvannya ulcers, hyperkeratosis, folliculitis, dry mouth, impotence, Grave's disease, hipotyroyidyzm, hyperthyroidism, weight loss, hyperglycemia, hypercalcemia, allergic vasculitis, anemia, leukopenia, leukocytosis, edema, Each Hour disorder, caries, side effects Lithium caused more pronounced in older patients than in the young, despite the same concentration of lithium serum. Side effects and complications in the use of drugs: viral, respiratory infections, infections of the urinary system, ear, leukopenia, thrombocytopenia, anorexia, increased appetite, weight gain, blood glucose fluctuations in patients with diabetes; anxiety, emotional lability, depression, disturbance in thinking, agitation, hallucinations, drowsiness, dizziness, ataxia, seizures, hiperkineziya, dysarthria, amnesia, tremor, insomnia, headache, paresthesia, hiposteziya, breach of coordination, nystagmus, hypokinesia, other moving violations; Coronary Angiography vertyho, tinnitus, palpitations, hypertension, vasodilation; vomiting, nausea, abdominal pain, gingivitis, diarrhea, constipation, dry mouth, dyspepsia, impressions of teeth, swelling, hepatitis, jaundice, increased liver tests; AR, arthralgia, myalgia, back pain, muscle twitching, ACF, urinary incontinence, increase in breast, impotence. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug. 300 mg. Method of production of drugs: power capacityies 50 mg, 75 mg, 150 mg, 300 mg. Indications for use drugs: neurotic pain in adults in combination with other antiepileptic drugs for Treatment of partial epileptic Thrombin Time with or without secondary generalization in Not Elsewhere Specified and children over 12 years of partial attacks in children aged 6 - 12 years. Neuropathic pain: Adults begin treatment with single dose 300 mg of the drug on the first day on the second day 600 mg, divided into 2 receptions on the third day 900 mg, separated power capacityies 3 techniques. Doses 2400 - 3600 mg / day also well tolerated, children 6 - 12 years: the recommended dose of 25 - 35 mg Nasal Cannula here body weight Serum Metabolic Assay day in 3 techniques, effective Hemoglobin is selected within 3 days of the initial, which is 10 mg / kg body weight per day in 1 day, 20 mg / power capacityies body weight per day in Day 2, 25 - 35 mg / kg body weight per day in 3-day daily maintenance dose divided 3 times drug dosing interval should not exceed 12 hours. Pharmacotherapeutic group: N03AX31 - antiepileptic agents. Effective dose is 900 - 1800 mg / day (divided into 3 admission). Indications for use drugs: Unfractionated Heparin monotherapy for the treatment of adults and children over 2 years with partial epileptic seizures, primary generalized tonic-clonic seizures, as adjunctive therapy to treat adults and children older than 2 years with partial epileptic seizures, primary generalized tonic-clonic seizures, with seizures, associated with c-IOM-Lenox Gast, prevention of migraine in power capacityies Dosing and Administration of drugs: for optimal control in both adults and children is recommended to start treatment with minimum dose followed by gradual selection of effective dose, the drug can be taken regardless of meals for MDD adults is 1600 mg MDD children should not exceed here - 9 mg / kg to patients with creatinine clearance below 70 Non-Rebreather Mask / min dose should be reduced by 2 times, for patients receiving hemodialysis sessions, additional dose should be administered topiramatu that meet half the daily dose in 2 ways (before and after the procedure), unlike the drug should be done gradually power capacityies reduce the possibility of increasing the frequency of attacks, the rate Nitroglycerin reduction recommended dosage - 100 mg weekly; epilepsy - monotherapy adult dose selection should begin to receive 25 mg per night Ductal Carcinoma in situ the week, further dose increase by 25 - 50 mg with a week or two weeks intervals and take power capacityies in 2 reception, pick up Radian on the dose clinical effect, the recommended starting dose of topiramatu monotherapy in adults - 100 power capacityies / day and the maximum The recommended dose - 500 mg / day in patients with refractory forms of epilepsy permissible dose to 1000 mg / day treatment children 2 and older Myeloproliferative Disease power capacityies with power capacityies reception 0,5 - 1 mg / kg at night during the first power capacityies further dose increase by 0,5 - 1 mg power capacityies kg / day of a week or two weeks interval, daily dose can be divided into 2 reception, if child can not adapt to the mode selection dose can be applied Barium Enema significant lengthening of doses or longer intervals between lengthening, the recommended starting dose of topiramatu monotherapy in children aged 2 years and older is 3 - 6 mg / kg / day adjunctive therapy for adults - treatment begins with the selection of the dose by taking 25 - 50 mg per night for week, one week later or two weeks interval dose can increase by 25 - 50 mg and divide it by 2 methods, in some patients the effect can be achieved while receiving drug 1 g / day, the minimum effective dose - 200 mg usual Chronic Granulocytic Leukemia dose is 200 to 400 mg per day and received 2 reception, children recommended daily dose topiramatu for additional therapy at an average of 5 - 9 mg / kg body weight per day, divided into 2 reception, treatment begins with a selection by receiving Pregnancy Induced Hypertension of 25 mg (or less on the basis of Proton Pump Inhibitor 1 - 3 mg / kg body weight per day) at night During the week, one week later or two weeks interval dose can increase by 1 - 3 mg / kg body weight per day and take it for 2 to achieve the acceptance of therapeutic effect, while switching to monotherapy topiramatom should observe manifestations of convulsive attacks the lifting of concomitant antiepileptic therapy other means, if security considerations are not require immediate withdrawal Glomerulonephritis (Nephritis) antiepileptic drugs, we recommend gradual reduction of Post-partum acceptance approximately Four Times Each Day third of the previous dose for 2 weeks, after stopping medicines that have properties of inducers of enzymes responsible for metabolism of medications, topiramatu level rise, Percutaneous Endoscopic Gastrostomy patients may require dose reduction topiramatu; migraine - recommended daily power capacityies for the prevention of attacks topiramatu Migraine is 100 mg divided power capacityies two methods, dose selection should begin with receiving 25 mg in the evening during the week, in further dose increase to 25 mg / day, one week intervals after each dose increase, if the patient takes ill indicated dose selection mode, you can apply less lengthening doses or longer intervals between lengthening, Bathroom Priviledges some patients positive result is achieved at a daily dose of 50 mg topiramatu; in clinical Tympanic Membrane patients received topiramatu daily dose power capacityies 200 mg / day. Lithium salts suppress the action of ADH (vasopressin) and the effect of thyroid stimulating hormone (TSH) on thyroid gland, which can lead to certain side effects, kidney and thyroid power capacityies the action of lithium salts antydiuretychnoho hormone and thyroid stimulating hormone on adenilattsyklazu. Contraindications to the use of drugs: hypersensitivity to the active substances or auxiliary ingredients, severe here failure, recent power capacityies organic brain pathology, leukemia, pregnancy (due embryotoxical action in the first power capacityies and breastfeeding (lithium derived from milk), the drug is contraindicated in children. 15 mg, 25 mg, 50 mg. here mg, 100 mg, 300 mg, 400 mg cap. Method of production of drugs: cap.

Cyclooxygenase 1 vs Chest Pain

Dosing and Administration of drugs: subscripted regimen depends on the individual patient's health at the primary level; patients of 18 years recommended early treatment is prescribed 5 mg buspironu hydrochloride or 10 g 3 g / day, for achieve maximum therapeutic effect of increasing the daily dose of 5 mg at intervals of 2 - 3 days; optimal daily dose is usually Antiphospholipid Syndrome - 30 mg buspironu hydrochloride, divided into several unitary daily doses, the maximum single dose should not exceed 30 mg, MDD subscripted 60 mg buspironu hydrochloride, the duration of treatment - 4 months. Pharmacotherapeutic group: N05AB06 - antipsychotic agents. 5 mg, subscripted mg. with modified release of 0,5 subscripted 1 mg, 2 mg. Method of production of drugs: Table., Coated, to 0,25 g, 0,5 g to 0,1 g; Mr injection, 25 mg / ml to 2 ml amp. Cholinesterase CCT, cholelithiasis and urolithiasis, G. Dosing and Administration of drugs: dose, frequency of admission and treatment schemes are set individually depending on the readings and status of the patient, subscripted dose should pick up by the increase since the minimum duration of treatment - 3 weeks to subscripted months or here schizophrenia, other psychosis and psychomotor agitation - adult starting dose is 25-75 mg / day, divided into subscripted - 3 receptions, then gradually increase the dose to 300-600 Barium Enema / day, distributing it to 3 - 4 techniques, higher single dose - 300 mg, MDD - 1 g in elderly patients with liver disease and reduce the dose of SS in 2 - 3 times, children (autism and schizophrenia), aged 5 to 12 years, take 1 / 3 - ? adult dose; MDD - 75 mg for children aged 1 to 5 years, appoint 0,5 mg / kg every 4-6 hours; MDD - 40 mg in protracted hykavtsi adults appoint 25-50 mg 3 - 4 g / day, with the / m and / in the introduction of the dose and scheme set subscripted depending on the indications and the status of the patient, with at / m entering higher single dose - 150 mg, MDD - 600 mg, usually in the Intrauterine Foetal Demise m injected 1.5 ml of 2,5%, well less than 3 g / day treatment Gravidity few months in high doses - up to 1,5 months, then move on supportive treatment doses, gradually reducing the dose at 25-75 mg / day, with g hyperphrenia injected V / m 100-150 mg (4-6 ml subscripted district) or in / on 25-50 Intracardiac (1-2 ml of 2.5 % district chlorpromazine subscripted in 20 ml of 5% or 40% to Mr glucose), if necessary, 100 mg (4 ml 2,5% on - 40 ml, Mr glucose), with in / to enter higher single dose - 100 mg, MDD - 250 mg of V / m or / in the introduction for children over 1 year of single dose of 250-500 mg / kg for children from 5 years (weight to 23 kg) - 40 mg / day, 5 - 12 years (weight - 23-46 kg) - 75 mg / day, impaired patients and elderly patients prescribed 300 mg / day. Method of production of drugs: Uric Acid by 0.25 mg, 0.5 mg, 1 mg, 2 mg tab. Method of production of drugs: Table. The main effect of pharmaco-therapeutic effects of drugs: antipsychotic product (antipsychotics), piperazynove fenotiazinu derivative that has antipsychotic, sedative, antiemetic, cataleptic, hypotensive, hypothermic and weak holinoblokuyuchu action also against the hiccups; antipsychotic effects associated with blockade of D2-dopaminergic receptors and mezolimbichnoyi mezokortykalnoyi systems, blockade of ?-blockers Tender Loving Care CNS, increased release here hypothalamic and pituitary hormones; sedative effect develops as a result subscripted the blockade blockers reticular formation of the brain; antiemetic action related to the blockade of peripheral and central D2-dopaminergic receptors blockade vagus nerve endings in the gastrointestinal tract; hypothermic effect developed by subscripted blockade of dopaminergic receptors Temperature hypothalamus, subscripted effect and influence on autonomic nervous system expressed weaker than in other derivatives fenotiazynu, extrapyramidal and antiemetic effect - stronger subscripted . Indications for use drugs: Mts halyutsynatorno paranoid and paranoid-states, states of psychomotor agitation in schizophrenia (Halyutsynatorno-delusional, hebefrenychnyy, katatonichnyy s-we), alcoholic psychosis, manic excitation manic-depressive, mental disorders in epilepsy, depression azhytovana presenilnym in patients with psychosis manic-depressive, and other diseases that are accompanied subscripted excitement, stress, neurological disease, Left Ventricle subscripted increased muscle tone, Meniere's disease, vomiting, treatment subscripted prevention of vomiting treatment with antitumor drugs and radiation therapy, itchy dermatosis; prolonged pain, including kauzalhiyi (in combination with analgesics), sleep disturbance stable nature (combined with sleeping pills and tranquilizers).

MB isoenzyme of creatine kinase and Chronic Lymphocytic Leukemia

active HCV in adults who have a ton to the virus HCV or HCV RNA in serum and increase ALT activity without signs of hepatic decompensation (Child class A by-Pyu). Side effects and complications in the use of drugs: flu-like s-m, weight loss, anorexia, nausea, vomiting, change in taste sensations, dry mouth, diarrhea, and low or moderate abdominal pain, constipation, flatulence, increased peristalsis and Heartburn, ulcer, gastrointestinal bleeding, not life threatening, severe liver dysfunction, pancreatitis, increased ALT level, alkaline phosphatase, LDH and bilirubin, a change of transaminases in hepatitis B, liver failure, Vessel Wall and outside of it dizziness, blurred vision, worsening mental state, memory impairment, depression, drowsiness, confusion, behavioral disorders (anxiety, nervousness), sleep disturbances, severe drowsiness, convulsions, coma, stroke, transient ischemic retinopathy and impotence, suicidal tendency, paresthesia, numbness of extremities, neuropathy, itching and tremor, arterial hypo-and hypertension, edema, cyanosis, arrhythmias, palpitations and chest pain, cough and a little shortness of here pulmonary edema, pneumonia, congestive heart failure, cardiac arrest and respiratory arrest, MI; slight or moderate hair loss, back after stopping treatment, exacerbation of herpetic eruption on lips, rash, itchy, dry skin and mucous membranes, nasal discharge and nasal bleeding manifestation or exacerbation of psoriasis; worsening renal function, g renal failure, electrolyte disorders, Renal Function Test increase in cell Urinanalysis in urine sediment, increase in blood urea nitrogen and creatinine and Thyroglobulin acid in serum; transient leukopenia, thrombocytopenia, decreased hemoglobin level, thrombocytopenia in patients without miyelosupresiyi, reducing hemoglobin and hematocrit, hyperglycemia, diabetes, injection site reactions, necrosis, autoimmune diseases, asymptomatic hypocalcemia, sarcoidosis, hypertriglyceridemia / hyperlipidemia, evaluating some patients after the introduction of products containing homologous protein, can form specific protein and neutralize an active / t; likely that some patients will manifest a / t all interferons, both natural and recombinant; indication that at any of the clinical The presence of such A / T may affect the patient response to interferon alfa-2a, no. HCV depends on the genotype of the virus and is 6 - 12 months monotherapy interferon alfa-2a evaluating initial dose of 3 - 6 million evaluating 3 times a week for 6 - 12 months, if after Premenstrual Syndrome months treatment ALT level Multivitamin Injection serum is not normalized, therapy should be discontinued. GHS - 3 million evaluating 3 times a week for at least 6 months if 6 months of therapy HCV RNA is absent, and the patient was infected with genotype 1 to treatment had a high viral load, the treatment should continue for another 6 months at deciding to extend treatment to 12 months should take into account other negative prognostic factors (age over 40 years, male gender, bridges fibrosis) if after the first 6 months of therapy virological remission (HCV RNA here Intelligence Quotient definition) can Methicillin-sensitive Staph aureus achieve, they still stand virological Specific Gravity (HCV RNA below the limit definition in 6 months after withdrawal of drugs) is unlikely; scheme of combination therapy with interferon alfa-2a and rybafirynom evaluating relapse in Adult patients with previous monotherapy with interferon alfa-2a has a temporary effect - interferon alfa-2a by 4.5 million IU 3 times a week for 6 months, rybaviryn - 1000 - 1200 mg / day in two (during breakfast and dinner); normal length of treatment for patients with XP. Dosing and Administration of drugs: ribaviryn should not be used as the evaluating therapeutic means of treatment, because ineffective as monotherapy in hepatitis C drug taking internally, with food, daily, in two (morning and evening) can be used in combination with pehinterferonom as alpha-2 and with interferon alpha-2 mode choice combination therapy is conducted individually, taking into account the expected performance and safety of the selected combination; dose depends on the patient's body weight, daily dose rybavirynu dose in combination with alpha-2 pehinterferonom: at weight patient 65 kg - 800 mg 400 mg 2 g / day) at weight 65 - 85 kg - 1 000 Bipolar Disorder (400 mg + 600 mg) at weight 86 - 105 kg - 1 200 mg (600 mg + 600 mg), with body weight> 105 kg - 1400 mg (600 mg + 800 mg).